Evaluation of serum level of carnitine in HIV-positive individuals and its possible explanatory factors

被引:2
作者
Salamzadeh, Jamshid [2 ]
Rezaee, Haleh [2 ]
Khalili, Hossein [1 ]
Jafari, Sirous [3 ]
Abdollahi, Alireza [4 ]
机构
[1] Univ Tehran Med Sci, Dept Clin Pharm, Fac Pharm, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Dept Clin Pharm, Fac Pharm, Tehran, Iran
[3] Univ Tehran Med Sci, Dept Infect Dis, Iranian Res Ctr HIV AIDS, Fac Med, Tehran, Iran
[4] Univ Tehran Med Sci, Dept Pathol, Fac Med, Tehran, Iran
关键词
carnitine; HIV; risk factors; ADIPOSE-TISSUE ALTERATIONS; ACETYL-L-CARNITINE; ANTIRETROVIRAL THERAPY; AIDS PATIENTS; METABOLIC COMPLICATIONS; LIPODYSTROPHY; DEFICIENCY; ABNORMALITIES; LIPOATROPHY; POPULATION;
D O I
10.2217/FVL.12.93
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Aims: This cross-sectional study evaluated the status of serum carnitine level and its possible explanatory factors in Iranian HIV-positive patients. Materials & methods: During a 1-year period, 210 HIV-positive patients older than 18 years of age were enrolled in the study. Serum carnitine concentrations of the patients were measured using radioimmunoassay kits. Probable correlations between the patients' demographic and clinical characteristics with their serum levels of carnitine were determined in this study. Results: In comparison with normal serum concentration of carnitine in a healthy population, 63.45% of the patients had carnitine deficiency. Receiving antiretroviral regimen, duration of HIV infection, receiving fibrate drugs, serum total cholesterol, fasting blood sugar and serum triglyceride had significant correlations with serum level of carnitine of the patients. Conclusion: The results of the present study showed that carnitine deficiency is prevalent in Iranian HIV/AIDS patients. Nutritional risk assessment of HIV-positive individuals at first visit and in the follow-up is essential.
引用
收藏
页码:1021 / 1028
页数:8
相关论文
共 50 条
[21]   Association Between ALT Level and the Rate of Cardio/Cerebrovascular Events in HIV-Positive Individuals: The D:A:D Study [J].
Sabin, Caroline A. ;
Ryom, Lene ;
Kovari, Helen ;
Kirk, Ole ;
de Wit, Stephane ;
Law, Matthew ;
Reiss, Peter ;
Dabis, Francois ;
Pradier, Christian ;
El-Sadr, Wafaa ;
Monforte, Antonella d'Arminio ;
Kamara, David ;
Phillips, Andrew N. ;
Lundgren, Jens D. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 (04) :456-463
[22]   Associations between baseline biomarkers and lung function in HIV-positive individuals [J].
MacDonald, David M. ;
Zanotto, Alexander D. ;
Collins, Gary ;
Baker, Jason, V ;
Czarnecki, Marcin ;
Loiza, Eliana ;
Nixon, Daniel E. ;
Papastamopoulos, Vasileios ;
Wendt, Chris H. ;
Wood, Robin ;
Kunisaki, Ken M. .
AIDS, 2019, 33 (04) :655-664
[23]   The SWITCHMRK studies: substitution of lopinavir/ritonavir with raltegravir in HIV-positive individuals [J].
Cocohoba, Jennifer .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (10) :1159-1163
[24]   Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort [J].
Pelchen-Matthews, Annegret ;
Ryom, Lene ;
Borges, Alvaro H. ;
Edwards, Simon ;
Duvivier, Claudine ;
Stephan, Christoph ;
Sambatakou, Helen ;
Maciejewska, Katarzyna ;
Portu, Jose Joaquin ;
Weber, Jonathan ;
Degen, Olaf ;
Calmy, Alexandra ;
Reikvam, Dag Henrik ;
Jevtovic, Djordje ;
Wiese, Lothar ;
Smidt, Jelena ;
Smiatacz, Tomasz ;
Hassoun, Gamal ;
Kuznetsova, Anastasiia ;
Clotet, Bonaventura ;
Lundgren, Jens ;
Mocroft, Amanda .
AIDS, 2018, 32 (16) :2405-2416
[25]   Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada [J].
Sophie Patterson ;
Angela Cescon ;
Hasina Samji ;
Keith Chan ;
Wendy Zhang ;
Janet Raboud ;
Ann N. Burchell ;
Curtis Cooper ;
Marina B. Klein ;
Sean B. Rourke ;
Mona R. Loutfy ;
Nima Machouf ;
Julio S. G. Montaner ;
Chris Tsoukas ;
Robert S. Hogg .
BMC Infectious Diseases, 15
[26]   Salivary Antioxidant and Oxidative Stress Marker Levels in HIV-positive Individuals [J].
Amjad, Samaneh Vaziri ;
Davoodi, Poorandokht ;
Goodarzi, Mohammad Taghi ;
Abdolsamadi, Hamidreza ;
Poorolajal, Jalal ;
Parsa, Shahryar ;
Paydari, Darvish ;
Ahmadi-Motamayel, Fatemeh .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2019, 22 (01) :59-64
[27]   Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada [J].
Patterson, Sophie ;
Cescon, Angela ;
Samji, Hasina ;
Chan, Keith ;
Zhang, Wendy ;
Raboud, Janet ;
Burchell, Ann N. ;
Cooper, Curtis ;
Klein, Marina B. ;
Rourke, Sean B. ;
Loutfy, Mona R. ;
Machouf, Nima ;
Montaner, Julio S. G. ;
Tsoukas, Chris ;
Hogg, Robert S. .
BMC INFECTIOUS DISEASES, 2015, 15
[28]   Magnetic resonance imaging evaluation of lipodystrophy in HIV-positive patients receiving highly active antiretroviral therapy [J].
Eichler, K. ;
Bickel, T. M. ;
Klauke, S. ;
Eisen, J. ;
Vogl, T. J. ;
Zangos, S. .
INTERNATIONAL JOURNAL OF STD & AIDS, 2015, 26 (08) :582-589
[29]   High smoking prevalence among HIV-positive individuals: A systematic review and meta-analysis [J].
Lindayani, Linlin ;
Yeh, Chun-Yin ;
Ko, Wen-Chien ;
Ko, Nai-Ying .
JOURNAL OF SUBSTANCE USE, 2020, 25 (01) :1-10
[30]   Clinical and epidemiologic characterization of photosensitivity in HIV-positive individuals [J].
Bilu, D ;
Mamelak, AJ ;
Nguyen, RHN ;
Queiroz, PC ;
Kowalski, J ;
Morison, WL ;
Martins, CR .
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2004, 20 (04) :175-183